Effectiveness of aspirin and aspririnmetformin combination preventing preeclampsia
Phase 3
Recruiting
- Conditions
- Preeclampsia.Pre-eclampsia
- Registration Number
- IRCT20140317017035N9
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 322
Inclusion Criteria
The singleton pregnant women who are high risk for uteroplacental ischemia and preclampsia based on increased uterine artery resistant on first trimester doppler ultarasonography.
Exclusion Criteria
Multiple pregnancy
Fetal aneuploidy
Fetal anomaly
Allergy to aspirin
Women who use aspirin or heparin before starting study
Coagulation disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease fetal mortality and morbidity due to preeclampsia. Timepoint: After birth. Method of measurement: Vital Signs.
- Secondary Outcome Measures
Name Time Method